Welcome to Markets Desk, let's get you caught up on what's moving.
U.S. equity indexes have shown remarkable resilience in the face of geopolitical shock, bouncing back swiftly following the initial strike on Iran and pushing on to fresh highs. It's a pattern markets have repeated before — fear spikes, smart money buys the dip, and the indexes grind higher once the worst-case scenario fails to materialize.
Shifting to software, Morningstar is flagging a valuation opportunity that hasn't appeared in roughly three years, with the sector trading at what analysts consider a meaningful discount to fair value. Microsoft is front and center in that conversation, with the research firm pushing back on the narrative that the company is trailing rivals in artificial intelligence — arguing instead that it may be the sector's quiet leader.
And on the institutional side, Capricorn Fund has made a sizable conviction play in the biotech space, picking up nearly seven hundred thousand shares of Axogen, the nerve repair specialist, in a position valued at over twenty-two million dollars. That kind of concentrated bet signals genuine conviction in the company's pipeline and commercial trajectory.
That's the tape. Markets Desk, signing off the floor.
